Literature DB >> 12939567

Insulin resistance, hypertension, and coronary heart disease.

Gerald Reaven1.   

Abstract

The goals of this review are two-fold: to examine the evidence in support of a role for insulin resistance and compensatory hyperinsulinemia in the pathogenesis of essential hypertension, and to evaluate the hypothesis that insulin resistance and its manifestations play major roles in the development of coronary heart disease in patients with essential hypertension. In both instances, only experimental results in human beings will be considered. Although it remains a scientific issue of great importance, the scope of this review precludes a discussion of the mechanistic link between insulin resistance/hyperinsulinemia and essential hypertension.

Entities:  

Mesh:

Year:  2003        PMID: 12939567      PMCID: PMC8101898          DOI: 10.1111/j.1524-6175.2003.01764.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  41 in total

1.  Fasting insulin in relation to subsequent blood pressure changes and hypertension in women.

Authors:  L Lissner; C Bengtsson; L Lapidus; K Kristjansson; H Wedel
Journal:  Hypertension       Date:  1992-12       Impact factor: 10.190

2.  Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.

Authors:  Markus C Stühlinger; Fahim Abbasi; James W Chu; Cindy Lamendola; Tracey L McLaughlin; John P Cooke; Gerald M Reaven; Philip S Tsao
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

3.  The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study.

Authors:  O T Raitakari; K V Porkka; T Rönnemaa; M Knip; M Uhari; H K Akerblom; J S Viikari
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

Review 4.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

5.  High triglycerides and low HDL cholesterol and blood pressure and risk of ischemic heart disease.

Authors:  J Jeppesen; H O Hein; P Suadicani; F Gyntelberg
Journal:  Hypertension       Date:  2000-08       Impact factor: 10.190

6.  Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension.

Authors:  A L Swislocki; B B Hoffman; G M Reaven
Journal:  Am J Hypertens       Date:  1989-06       Impact factor: 2.689

7.  Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension.

Authors:  R J Jarrett; H Keen; M McCartney; J H Fuller; P J Hamilton; D D Reid; G Rose
Journal:  Int J Epidemiol       Date:  1978-03       Impact factor: 7.196

8.  Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men.

Authors:  E T Skarfors; H O Lithell; I Selinus
Journal:  J Hypertens       Date:  1991-03       Impact factor: 4.844

9.  Insulin resistance in secondary hypertension.

Authors:  A Shamiss; J Carroll; T Rosenthal
Journal:  Am J Hypertens       Date:  1992-01       Impact factor: 2.689

10.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

View more
  15 in total

1.  Insulin resistance explains the relationship between novel cardiovascular risk factors and hypertension. The Telde Study.

Authors:  A M Wägner; J C Wiebe; M Boronat; P Saavedra; D Marrero; F Varillas; F J Nóvoa
Journal:  J Endocrinol Invest       Date:  2010-10-27       Impact factor: 4.256

2.  Genetic variants at PSMD3 interact with dietary fat and carbohydrate to modulate insulin resistance.

Authors:  Ju-Sheng Zheng; Donna K Arnett; Laurence D Parnell; Yu-Chi Lee; Yiyi Ma; Caren E Smith; Kris Richardson; Duo Li; Ingrid B Borecki; Jose M Ordovas; Katherine L Tucker; Chao-Qiang Lai
Journal:  J Nutr       Date:  2013-01-09       Impact factor: 4.798

3.  Relationship among 25-hydroxyvitamin D concentrations, insulin action, and cardiovascular disease risk in patients with essential hypertension.

Authors:  Fahim Abbasi; David Feldman; Michael P Caulfield; Feras M Hantash; Gerald M Reaven
Journal:  Am J Hypertens       Date:  2014-08-19       Impact factor: 2.689

4.  Impact of acute psychological stress on cardiovascular risk factors in face of insulin resistance.

Authors:  Kristian T Jones; Richard C Shelton; Jun Wan; Li Li
Journal:  Stress       Date:  2016-09-20       Impact factor: 3.493

Review 5.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

6.  Serum insulin is significantly related to components of the metabolic syndrome in Japanese working men.

Authors:  Tomoyuki Kawada; Hirofumi Inagaki; Yoko Wakayama; Qing Li; Masao Katsumata
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-04       Impact factor: 3.738

7.  Role of the IRS-1 and/or -2 in the pathogenesis of insulin resistance in Dahl salt-sensitive (S) rats.

Authors:  Marlene F Shehata
Journal:  Heart Int       Date:  2009-06-30

Review 8.  Secondary hypertension: obesity and the metabolic syndrome.

Authors:  Gregory M Singer; John F Setaro
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-07       Impact factor: 3.738

Review 9.  Thermogenic Fat: Development, Physiological Function, and Therapeutic Potential.

Authors:  Bruna B Brandão; Ankita Poojari; Atefeh Rabiee
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

10.  Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats.

Authors:  Marlene F Shehata
Journal:  Cardiovasc Diabetol       Date:  2008-06-21       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.